Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amylyx, Arrowhead, Astrazeneca, Atara, Bluejay, Daiichi Sankyo, Disc Medicine, Dyne, Formycon, GSK, Janssen-Cilag, Johnson & Johnson, Klinge Biopharma, Kalvista, Nacuity, Replimune, Solid Biosciences.